000			01978 a2200613 4500
005			20250517140844.0
264		0	_c20180326
008			201803s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.15322 _2doi
040			_aNLM _beng _cNLM
100	1		_aHowell, Jessica
245	0	0	_aIntegration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib. _h[electronic resource]
260			_bOncotarget _cMay 2017
300			_a36161-36170 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBiomarkers _xmetabolism
650	0	4	_aCarcinoma, Hepatocellular _xdiagnosis
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInflammation _xdiagnosis
650	0	4	_aLiver Neoplasms _xdiagnosis
650	0	4	_aLymphocytes _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aNeutrophils _ximmunology
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xtherapeutic use
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aRisk
650	0	4	_aSorafenib
650	0	4	_aSurvival Analysis
700	1		_aPinato, David J
700	1		_aRamaswami, Ramya
700	1		_aArizumi, Tadaaki
700	1		_aFerrari, Carlotta
700	1		_aGibbin, Antonello
700	1		_aBurlone, Michela E
700	1		_aGuaschino, Giulia
700	1		_aToniutto, Pierluigi
700	1		_aBlack, James
700	1		_aSellers, Laura
700	1		_aKudo, Masatoshi
700	1		_aPirisi, Mario
700	1		_aSharma, Rohini
773	0		_tOncotarget _gvol. 8 _gno. 22 _gp. 36161-36170
856	4	0	_uhttps://doi.org/10.18632/oncotarget.15322 _zAvailable from publisher's website
999			_c26891506 _d26891506